COVID-19 Vaccine Information Center

Updated Vaccine Schedules

As of May 1, 2023, the CDC recommends that people ages 6 months and older receive at least 1 bivalent mRNA COVID-19 vaccine to be considered up-to-date, regardless of your vaccine status. 

Adults aged 65 and older and people aged 6 and older who are immunocompromised may now choose to receive an additional bivalent COVID vaccine this spring. The bivalent vaccine is the only vaccine available now. 

Select the brand of vaccine that you've had to see what is recommended for you. If you've had more than one mRNA brand, select either brand.

Pfizer              Moderna              Novavax

 

NDSU Campus Updates

COVID-19 Vaccine Information for Students

Students can receive free Pfizer and Moderna COVID vaccinations at Student Health Service. Call 701-231-7331 to schedule your appointment.

NDSU's Department of Public Health is providing free COVID-19 home test kits to all students, faculty, and staff at NDSU. You can pick up test kits at the following locations:

  • NDSU Bookstore
  • NDSU Library
  • Barry Hall - room 102
  • Renaissance Hall - room 108
  • NDSU Student Health Service

 

Case & Vaccine Monitoring ​

NDDoH Data Dashboard: Vaccines Administered & Case Counts

North Dakota Stories: COVID-19 Impact Wall

CDC Data Tracker: Vaccine Doses Administered in the US and by State

CDC COVID-19: News & Highlights 

 About the COVID-19 Vaccine​

COVID-19 vaccines are safe and effective. Individuals that are up-to-date on their vaccines are less likely to have symptomatic infection, severe disease, hospitalization, and death compared to nonvaccinated individuals. Getting vaccinated is the best way to protect ourselves and those around us from COVID-19. Read the latest studies. ​

Most people 6 months of age and older are eligible to be vaccinated against COVID-19. The Pfizer-BioNTech COVID-19 vaccine (known as Comirnaty, pronounded koe-mire'-na-tee) and the Moderna vaccine (known as Spikevax) has full FDA approval for individuals 6 months of age and older. 

The public can be very confident that these vaccines meet high standards for safety, effectiveness, and manufacturing quality . Read more about the FDA approval and the Biologics License Applications (BLA) process. 

Subscribe to Email Updates

Vaccine Safety

While some people may experience mild symptoms after receiving the vaccine, serious adverse events are rare. Medical providers and vaccine experts believe that the benefits of receiving the COVID-19 vaccine greatly outweigh the risks. ​

COVID-19 vaccines were studied in clinical trials in tens of thousands of people from diverse ages, races and ethnicities. Manufacturers had to meet rigorous safety and efficacy standards before their vaccines were authorized for use in the U.S. Today, over 675 million people in the U.S. have received COVID-19 vaccines under the most intensive safety monitoring in our history – reassuring us that COVID-19 vaccines are safe and effective. ​

Learn More About COVID-19 Vaccine Safety

 
Available Vaccines & Eligibility 

Currently, there are four COVID-19 vaccines authorized for use in the US: Moderna, Pfizer, Johnson & Johnson (Janssen), and Novavax. Moderna and Pfizer’s COVID-19 vaccines are mRNA (messenger RNA) vaccines. Johnson & Johnson is a non-replicating viral vector vaccine. Novavax is a protein subunit vaccine. These vaccines teach your body to fight off COVID-19. Vaccines do not stick around in our body for long, nor do they give you COVID-19. Rather, if we come in contact with the virus that causes COVID-19, the vaccine has prepped our immune system to recognize the virus and fight off the infection more effectively.  

Most children and adults age 6 months and older are now eligible to receive the COVID-19 vaccine. 

As of May 1, 2023, the CDC recommends that people ages 6 months and older receive at least 1 bivalent mRNA COVID-19 vaccine to be considered up-to-date, regardless of your vaccine status. 

Select the brand of vaccine you've had to see what is recommended for you. If you've had more than one mRNA brand, select one either brand. 

Pfizer              Moderna              Novavax

About the Bivalent Vaccine

The bivalent vaccine formula, which originally came out in fall of 2022 as a booster, is the only mRNA COVID vaccine availabile now. This formula boosts immunity against the original coronavirus strain and also protects against the newer Omicron variants that account for most of the current cases. This formula is designed for optimal protection against the virus and address waning vaccine effectiveness over time. 

As per the CDC’s recommendations, the new bivalent vaccine replaces the existing monovalent vaccine, therefore the monofvalent vaccine is no longer authorized for use.  

Learn more about the COVID-19 Vaccine. 

Get Your Vaccine

COVID-19 Vaccine Locator or text GETVAX to 438829 to find a vaccine near you!

 

Top of page